Association Between Nonselective Beta-Blocker Use and Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Without Cirrhosis and Decompensation

Background: Nonselective beta-blockers (NSBBs) can reduce the incidence or mortality of certain types of cancers, and NSBBs exert a protective effect on hepatocellular carcinoma (HCC) in patients with cirrhosis. However, the potential preventive effect of NSBBs has not yet been investigated in patie...

Descripción completa

Detalles Bibliográficos
Autores principales: Cheng, He-Yun, Lin, Hsiu C., Lin, Hsiu L., Uang, Yow S., Keller, Joseph J., Wang, Li H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777254/
https://www.ncbi.nlm.nih.gov/pubmed/35069216
http://dx.doi.org/10.3389/fphar.2021.805318

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8777254/
https://www.ncbi.nlm.nih.gov/pubmed/35069216
http://dx.doi.org/10.3389/fphar.2021.805318

Ejemplares similares